DMD Celsis microsomes mean better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 6, 2006; DOI: 10.1124/dmd.106.012138


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.012138v1
dmd.106.012138v2
dmd.106.012138v3
35/3/402    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lickteig, A. J
Right arrow Articles by Cherrington, N. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lickteig, A. J
Right arrow Articles by Cherrington, N. J


Received for publication August 4, 2006.
Revised November 27, 2006.
Accepted for publication December 1, 2006.

DIFFERENTIAL REGULATION OF HEPATIC TRANSPORTERS IN THE ABSENCE OF TNF-{alpha}, IL-1{beta}, IL-6 AND NF-{kappa}B IN TWO MODELS OF CHOLESTASIS

Andrew J Lickteig 1, Angela L Slitt 2, Melek C Arkan 3, Michael Karin 4, Nathan J Cherrington 1*

1 University of Arizona 2 University of Rhode Island 3 Technical University of Munich 4 University of California, San Diego

* Address correspondence to: E-mail: cherrington{at}pharmacy.arizona.edu

Abstract

Hepatic transporters are responsible for uptake and efflux of bile acids and xenobiotics as an essential aspect of liver function. When normal vectorial transport of bile acids by the apical uptake and canalicular excretion transporters is disrupted, cholestasis ensues, leading to accumulation of toxic bile constituents and considerable hepatocellular damage. The purpose of this study was to assess the role of cytokines and Nuclear Factor-{kappa}B (NF-{kappa}B) in the transcriptional regulation of transporters in two models of cholestasis, lipopolysaccharide (LPS) administration and bile-duct ligation (BDL). In wild type (WT) and knockout mouse strains lacking TNF Receptor-1 (TNFR1), Interleukin (IL)-1-Receptor I (RI), IL-6 or I{kappa}B kinase {beta}, transporter mRNA levels in liver were determined using branched DNA signal amplification 16h following LPS administration or 3 days after BDL. In WT mice, LPS administration tended to decrease mRNA levels of Oat2, Ntcp, Oatp1, Oatp4, Bsep, Mrp2 and Mrp6 compared to saline treatment, whereas it increased Mrp1, 3 and 5 levels. Similar changes were observed in each knockout strain following LPS administration. Conversely, BDL decreased only Oatp1 expression in WT mice, meanwhile increasing expression of Mrp1, 3, 5, and Oatp2 expression in both WT and knockout strains. Because the transcriptional effects of BDL- and LPS-induced cholestasis reflect dissimilarity in hepatic transporter regulation, we conclude that these disparities are not due to the individual activity of TNF-{alpha}, IL-1, IL-6 or NF-{kappa}B, but to the differences in the mechanism of cholestasis.


Key words: cytokines, gene regulation, hepatobiliary transport, liver disease, MRP, organic anion transport, transcriptional regulation, transporters


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
C. Chen, J. L. Stock, X. Liu, J. Shi, J. W. Van Deusen, D. A. DiMattia, R. G. Dullea, and S. M. de Morais
Utility of a Novel Oatp1b2 Knockout Mouse Model for Evaluating the Role of Oatp1b2 in the Hepatic Uptake of Model Compounds
Drug Metab. Dispos., September 1, 2008; 36(9): 1840 - 1845.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. D. Beilke, D. G. Besselsen, Q. Cheng, S. Kulkarni, A. L. Slitt, and N. J. Cherrington
Minimal Role of Hepatic Transporters in the Hepatoprotection against LCA-Induced Intrahepatic Cholestasis
Toxicol. Sci., March 1, 2008; 102(1): 196 - 204.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.